[Contemporary views of the role of HPV infection in oncogenesis in cervical cancer].
Cervical cancer is the second most common cancer of the woman worldwide. Infection with some genotypes of human papillomavirus (HPV) is the most important risk factor associated to cervical cancer, particularly HPV type 16 and 18 and potentially 31 and 45. Till now specific treatment or vaccination is not available but recently published results can be the first step to produce specific vaccination and reduce the number of cervical cancer. HPV has an influence on oncogenesis, but there are also mechanisms not depending on HPV infection. Recently published Institute Pasteur' data concerning the HPV genom may be the first step to produce specific vaccination.